Krystal Biotech Inc (KRYS)

EBITDA

$220.00M

TTM · Period ending: · USD

KRYS logo

KRYS EBITDA

Latest reported$220.00M
KRYS EBITDA (-$1.14M → $220.00M)
High-resolution chart · PNG

KRYS ebitda history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Krystal Biotech Inc EBITDA — Annual fiscal periods (USD)
Period endingEBITDA (USD)
196,022,000
109,909,000
-92,220,000
-116,141,001
-65,309,000
-30,316,000
-18,114,000
-10,748,000
-4,634,000
-1,141,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.